可编程控制Pickering乳液中的活性成分释放,使用光
Jie Liu1, Zichun Song1, Jing Luo1
1Key Laboratory of Synthetic and Biological Colloids, Ministry of Education, School of Chemical and Material Engineering, Jiangnan University, Wuxi, Jiangsu, 214122, China.
Small (Weinheim an der Bergstrasse, Germany)
|March 4, 2025
概括
这项研究在皮克林乳液中引入了对光敏感的纳米,用于控制释放. 紫外线触发这些纳米门的打开,使可编程的活性物质可以在不破坏乳液的情况下提供.
科学领域:
- 合体和表面科学科学
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
背景情况:
- 皮克林乳液对于在药品和化品等多个领域提供活性成分至关重要.
- 目前用于释放封装物质的方法通常需要乳液破坏,这对可编程释放具有挑战性.
- 需要在稳定的乳液系统中对活性成分进行非侵入性,受控释放机制.
研究的目的:
- 开发一个皮克林乳液系统,具有光敏的合体层作为纳米门的作用.
- 通过使用紫外线作为远程刺激来证明封装活性物质的可编程释放.
- 通过调整系统参数来研究释放动力学的控制.
主要方法:
- 在油水界面上,用阿佐烯功能化的二氧化颗粒制造一个合层.
- 利用紫外线和可见光诱导亚博的 cis-trans 异体化,控制粒子间隙 (纳米).
- 在受控光照射周期下监测模型活性物质 (烯) 的释放.
主要成果:
- 证明了一种"纳米门"效应,在这种效应中,紫外线辐射在合颗粒之间打开了空隙.
- 从皮克林乳液滴中实现可编程的烯释放,由紫外线触发.
- 通过调整颗粒大小和光照持续时间来精确控制烯释放量,保持乳液稳定性.
结论:
- 开发了一种新的皮克林乳液系统,使用光激活的纳米来进行可编程释放.
- 该系统提供非侵入性,使用紫外线可见光对活性物质释放的远程控制.
- 为食品,化品和制药领域的应用提供了一个多功能平台,需要控制的交付.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...


